Integrated Wealth Concepts’s Harmony Biosciences HRMY Stock Holding History

Integrated Wealth Concepts’s Portfolio HRMY Stock Details HRMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$64.7K	Buy	+1,777	New	+$56.1K	﹤0.01%	3162

Other funds holding HRMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Integrated Wealth Concepts's HRMY Position: Q2 2026 in Review

Integrated Wealth Concepts opened a new position in Harmony Biosciences (HRMY) in Q2 2026: 1,777 shares worth $64.7K. The stake represents ﹤0.01% of the portfolio and ranks #3162 among its holdings.

326 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

Integrated Wealth Concepts held 1,777 shares of Harmony Biosciences worth $64.7K as of Q2 2026.
Harmony Biosciences was a new Integrated Wealth Concepts position in Q2 2026.
Harmony Biosciences made up ﹤0.01% of Integrated Wealth Concepts's portfolio in Q2 2026, its #3162 holding.
326 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Integrated Wealth Concepts's 13F filing for Q2 2026, filed 12 Aug 2026.